Skip to Main Content
Qurgen Qurgen
Menu Button

June–July 2025

Brand Icon
Qurgen successfully produced two additional GMP-scale batches of SON-DP anti-tumor transcription factor protein drug for use in Phase I clinical trials in the U.S. and China. 

Recent news & press

2026
Prof Wang was invited to attend Tigermed's ASCO Pre-Event Webinar as a Speaker to introduce...
Learn More
Apr. 2026
no infusion related reaction (IRR) has occurred during the 48-hour continuous infusion by pump, this...
Learn More